Emma – Interview 10

Emma enrolled her son in a clinical trial for the Ketogenic Diet when he was aged seven years. She says it is the best thing to have happened to him. Matthew is now off his Ketogenic Diet and Emma says it has changed all their lives for the better.

Emma aged 42 years is divorced, describes herself as White British and mother of two children ages 15 and 13 years. She gave up her work to take care of her son who has experienced seizures since the age of nine months and was diagnosed with Dravet Syndrome at the age of 14 years.

Emma got involved with a clinical trial because her son’s epilepsy wasn’t being controlled with medication. Life was pretty miserable for him and for them as a family. Emma tried several things to help Matthew’s condition but nothing seemed to work. When Matthew was aged two years she came across the Ketogenic Diet which is a dietary treatment for intractable epilepsy. However, at the time there was little support for the diet and little medical evidence, and as such it was considered that drugs were the best option for Matthew. It wasn’t until Matthew was coming up to his seventh birthday and the cupboard was bare; as far as other treatments that she began to again explore the Ketogenic Diet. By coincidence, a clinical trial was being conducted at a hospital in London, and Emma jumped at the opportunity that her son might be able to take part. She says it is the best thing to have happened to him. Matthew is now off his medication and Emma says it has changed all their lives.

Emma had previously been involved in clinical trials so had some basic understanding about how they worked, she also realised that as the trial was a randomised controlled trial, that Matthew might be allocated to a control group. However, she was prepared to take this risk and wait for the treatment than continue as they had been doing for nearly seven years. She also knew that being on the trial, Matthew would be closely monitored. So for Emma this was the best option all round. Fortunately, Matthew was in the treatment group, which meant he could start the diet immediately. Emma says that within two weeks Matthew was showing signs of improvement, the number of seizures he was experiencing weekly was markedly reduced. Within eight months of being on the diet, Matthew had been weaned off all his medication.

Because of the nature of the diet and the research requirements, Emma said it had made her focus on her son, on the treatment, the difference it was making and as a result actually felt more in control than she had when Matthew was on medication. Although the dietary regime was rigid and took a while to adjust, and required her to be very organised, she felt that it had all been worth it. Her son is now off his medication, is happy and at the age of 15 years continues to live with her and her daughter at home.

Emma is now the Chief Executive Officer of the Charity Matthew’s Friends; that helps to raise money to continue research into the Ketogenic Diet and support other families whose children have epilepsy. She feels it is important to get medical evidence to support the benefits of the diet so that other children can be helped. In terms of advice to other parents who may be thinking of enrolling their child in a clinical trial, Emma recognises that it may depend on the type of clinical trial but he would always consider it because they are very closely monitored and have to adhere to very strict rules. Her only regret is that the Diet wasn’t available when Matthew was younger, but understands that seven years ago the diet may not have been of benefit to Matthew as it has only been through continued research that the diet has improved and more is known about it.

Emma didnt mind the hospital appointments and the monitoring; she knew her son was being closely…

Age at interview 42

Gender Female

Publication of results has certainly helped to increase awareness of the assessed diet, but still…

Age at interview 42

Gender Female

Starting the trial in the school holidays was best for Emma and her son, so they had time to…

Age at interview 42

Gender Female

Emmas son continued with the diet after the trial had ended. Having a good relationship with her…

Age at interview 42

Gender Female

She wishes her son had had the diet earlier, but the clinical trial was important to assess…

Age at interview 42

Gender Female

Even though there were follow-up meetings, parents sometimes still felt a bit abandoned at the…

Age at interview 42

Gender Female

More research is needed into diets for children with epilepsy as well as research into the causes…

Age at interview 42

Gender Female

Emmas son was randomised to receive the diet straight away. Some parents were in the control…

Age at interview 42

Gender Female

Emma was keen to take part in a trial for dietary changes in children with epilepsy, not only was…

Age at interview 42

Gender Female

Emma understood why some parents would be upset to be in the control group.

Age at interview 42

Gender Female